Overview
INSM market data
Price History
INSM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$6.42 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.86 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -76.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $90.39 – $212.75 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $28.5B · P/B 50.23 · P/S 25.01.
Company News
JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $175Benzinga · Aug 10, 2026, 6:53 PM
Truist Securities Reiterates Buy on Insmed, Raises Price Target to $195Benzinga · Aug 10, 2026, 5:53 PM
Guggenheim Maintains Buy on Insmed, Lowers Price Target to $205Benzinga · Aug 7, 2026, 5:04 PM
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $169Benzinga · Aug 7, 2026, 1:56 PM
Evercore ISI Group Maintains Outperform on Insmed, Raises Price Target to $170Benzinga · Aug 7, 2026, 12:40 PM
S&P 500, Dow Fall as Brent Jumps 4%, SanDisk Trims Losses: Stock Market TodayBenzinga · Aug 6, 2026, 5:32 PM
Crude Oil Gains 2%; Keurig Dr Pepper Earnings Top ViewsBenzinga · Aug 6, 2026, 4:04 PM
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On ThursdayBenzinga · Aug 6, 2026, 2:01 PM
Insmed shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.Benzinga · Aug 6, 2026, 11:25 AM
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M EstimateBenzinga · Aug 6, 2026, 11:10 AM